Extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest: first results and outcomes of a newly established ECPR program in a large population area.


Journal

Perfusion
ISSN: 1477-111X
Titre abrégé: Perfusion
Pays: England
ID NLM: 8700166

Informations de publication

Date de publication:
04 2022
Historique:
pubmed: 26 2 2021
medline: 21 4 2022
entrez: 25 2 2021
Statut: ppublish

Résumé

Out-of-hospital cardiac arrest (OHCA) is associated with excessively high mortality rates. Recent studies suggest benefits from extracorporeal cardiopulmonary resuscitation (ECPR) performed in selected patients. We sought to present the first results from our interdisciplinary ECPR program with a particular focus on early outcomes and potential risk factors associated with in-hospital mortality. Between January 2016 and December 2019, 44 patients who underwent ECPR selected according to our institutional ECPR protocol were retrospectively analyzed regarding pre-hospital, in-hospital, and early outcome parameters. Patients were divided into survivors (S) and non-survivors (NS). Statistical analysis of risk factors regarding in-hospital mortality of the patient cohort analyzed was performed. The mean age of the population was 53 ± 12 years, with most patients being male ( Establishing ECPR programs in large population areas offers the option to improve survival rates for OHCA patients. Stringent compliance of institutional criteria (mainly age, witnessed arrest, and time of pre-hospital resuscitation) and providing ECPR to strictly selected patients seems to be a vital factor for such programs' success. Pre-clinical settings and therapeutic measures must be adjusted in this regard to improve outcomes for this highly demanding patient cohort.

Identifiants

pubmed: 33626985
doi: 10.1177/0267659121995995
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

249-256

Auteurs

Ilija Djordjevic (I)

Department of Cardiothoracic Surgery, University Hospital Cologne, Heart Centre, Cologne, Germany.

Christopher Gaisendrees (C)

Department of Cardiothoracic Surgery, University Hospital Cologne, Heart Centre, Cologne, Germany.

Christoph Adler (C)

Department of Cardiology, University Hospital Cologne, Heart Centre, Cologne, Germany.
Department of Emergency Medicine, Cologne Fire Department, Cologne, Germany.

Kaveh Eghbalzadeh (K)

Department of Cardiothoracic Surgery, University Hospital Cologne, Heart Centre, Cologne, Germany.

Simon Braumann (S)

Department of Cardiology, University Hospital Cologne, Heart Centre, Cologne, Germany.

Borko Ivanov (B)

Department of Cardiothoracic Surgery, University Hospital Cologne, Heart Centre, Cologne, Germany.

Julia Merkle (J)

Department of Cardiothoracic Surgery, University Hospital Cologne, Heart Centre, Cologne, Germany.

Antje-Christin Deppe (AC)

Department of Cardiothoracic Surgery, University Hospital Cologne, Heart Centre, Cologne, Germany.

Elmar Kuhn (E)

Department of Cardiothoracic Surgery, University Hospital Cologne, Heart Centre, Cologne, Germany.

Robert Stangl (R)

Department of Emergency Medicine, Cologne Fire Department, Cologne, Germany.

Alex Lechleuthner (A)

Department of Emergency Medicine, Cologne Fire Department, Cologne, Germany.

Christian Miller (C)

Department of Emergency Medicine, Cologne Fire Department, Cologne, Germany.

Roman Pfister (R)

Department of Cardiology, University Hospital Cologne, Heart Centre, Cologne, Germany.

Navid Mader (N)

Department of Cardiothoracic Surgery, University Hospital Cologne, Heart Centre, Cologne, Germany.

Stephan Baldus (S)

Department of Cardiology, University Hospital Cologne, Heart Centre, Cologne, Germany.

Anton Sabashnikov (A)

Department of Cardiothoracic Surgery, University Hospital Cologne, Heart Centre, Cologne, Germany.

Thorsten Wahlers (T)

Department of Cardiothoracic Surgery, University Hospital Cologne, Heart Centre, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH